445
Participants
Start Date
May 31, 2006
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
Dexlansoprazole MR
Dexlansoprazole MR 30 mg, capsules, orally, once daily for up to six months.
Dexlansoprazole MR
Dexlansoprazole MR 60 mg, orally, once daily for up to six months.
Placebo
Dexlansoprazole placebo-matching capsules, orally, once daily for up to six months.
Huntsville
Tuscon
Anaheim
Azusa
Carmichael
Chula Vista
Cypress
Fresno
Garden Grove
Harrisburg
Irvine
Lancaster
Mission Hills
Oakland
Orange
Pasadena
San Diego
San Luis Obispo
Boulder
Colorado Springs
Wheat Ridge
Boynton Beach
Jupiter
Miami
New Smyma Beach
Ocala
St. Petersburg
Zephyrhills
Atlanta
Honolulu
Boise
Moline
Oak Forrest
Rockford
Clive
Lexington
Baton Rouge
Metairie
Chevy Chase
Hollywood
Lutherville
Prince Federick
Chaska
Jackson
Jefferson City
Washington
Egg Harbor
Albuquerque
Binghamton
Rochester
Greensboro
High Point
Raleigh
Bismarck
Dayton
Mogadore
Oklahoma City
Medford
Portland
Duncansville
Lansdale
Anderson
Mt. Pleasant
Bristol
Chattanooga
Germantown
Jackson
Kingsport
Nashville
Amarillo
Fort Worth
Houston
San Antonio
Ogden
Charlottesville
Chesapeake
Spokane
Tacoma
Milwaukee
Monroe
Kippa-Ring
St. John's
Newmarket
Richmond Hill
Toronto
Longueuil
Regina
Hradec Králové
Tallinn
Riga
Valmiera
Kaunas
Panevezys
Vilnius
Bratislava
Nitra
Prešov
Sučany
Lead Sponsor
Takeda
INDUSTRY